Advanced

Fast-track access to urologic care for patients with macroscopic haematuria is efficient and cost-effective : results from a prospective intervention study

Liedberg, Fredrik LU ; Gerdtham, Ulf LU ; Gralén, Katarina; Gudjonsson, Sigurdur LU ; Jahnson, Staffan; Johansson, Irene; Hagberg, Oskar LU ; Larsson, Staffan; Lind, Anna Karin and Löfgren, Anneli LU , et al. (2016) In British Journal of Cancer 115. p.770-775
Abstract

Background:The delay between onset of macroscopic haematuria and diagnosis of bladder cancer is often long.Methods:We evaluated timely diagnosis and health-care costs for patients with macroscopic haematuria given fast-track access to diagnostics. During a 15-month period, a telephone hotline for fast-track diagnostics was provided in nine Swedish municipalities for patients aged ⩾50 years with macroscopic haematuria. The control group comprised 101 patients diagnosed with bladder cancer in the same catchment area with macroscopic haematuria who underwent regular diagnostic process.Results:In all 275 patients who called ‘the Red Phone’ hotline were investigated, and 47 of them (17%) were diagnosed with cancer and 36 of those had bladder... (More)

Background:The delay between onset of macroscopic haematuria and diagnosis of bladder cancer is often long.Methods:We evaluated timely diagnosis and health-care costs for patients with macroscopic haematuria given fast-track access to diagnostics. During a 15-month period, a telephone hotline for fast-track diagnostics was provided in nine Swedish municipalities for patients aged ⩾50 years with macroscopic haematuria. The control group comprised 101 patients diagnosed with bladder cancer in the same catchment area with macroscopic haematuria who underwent regular diagnostic process.Results:In all 275 patients who called ‘the Red Phone’ hotline were investigated, and 47 of them (17%) were diagnosed with cancer and 36 of those had bladder cancer. Median time from patient-reported haematuria to diagnosis was 29 (interquartile range (IQR) 14−104) days and 50 (IQR 27−165) days in the intervention and the control group, respectively (P=0.03). The median health-care costs were lower in the intervention group (655 (IQR 655−655) EUR) than in the control group (767 (IQR 490−1096) EUR) (P=0.002).Conclusions:Direct access to urologic expertise and fast-track diagnostics is motivated for patients with macroscopic haematuria to reduce diagnostic intervals and lower health-care expenditures.British Journal of Cancer advance online publication, 25 August 2016; doi:10.1038/bjc.2016.265 www.bjcancer.com.

(Less)
Please use this url to cite or link to this publication:
author
, et al. (More)
(Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
urologic care , macroscopic haematuria
in
British Journal of Cancer
volume
115
pages
770 - 775
publisher
Nature Publishing Group
external identifiers
  • scopus:84983421935
  • wos:000384576100002
ISSN
0007-0920
DOI
10.1038/bjc.2016.265
language
English
LU publication?
yes
id
de192e7d-2b01-4d70-9f55-a89f61cb7b1b
date added to LUP
2016-09-21 12:31:08
date last changed
2017-09-18 11:29:56
@article{de192e7d-2b01-4d70-9f55-a89f61cb7b1b,
  abstract     = {<p>Background:The delay between onset of macroscopic haematuria and diagnosis of bladder cancer is often long.Methods:We evaluated timely diagnosis and health-care costs for patients with macroscopic haematuria given fast-track access to diagnostics. During a 15-month period, a telephone hotline for fast-track diagnostics was provided in nine Swedish municipalities for patients aged ⩾50 years with macroscopic haematuria. The control group comprised 101 patients diagnosed with bladder cancer in the same catchment area with macroscopic haematuria who underwent regular diagnostic process.Results:In all 275 patients who called ‘the Red Phone’ hotline were investigated, and 47 of them (17%) were diagnosed with cancer and 36 of those had bladder cancer. Median time from patient-reported haematuria to diagnosis was 29 (interquartile range (IQR) 14−104) days and 50 (IQR 27−165) days in the intervention and the control group, respectively (P=0.03). The median health-care costs were lower in the intervention group (655 (IQR 655−655) EUR) than in the control group (767 (IQR 490−1096) EUR) (P=0.002).Conclusions:Direct access to urologic expertise and fast-track diagnostics is motivated for patients with macroscopic haematuria to reduce diagnostic intervals and lower health-care expenditures.British Journal of Cancer advance online publication, 25 August 2016; doi:10.1038/bjc.2016.265 www.bjcancer.com.</p>},
  author       = {Liedberg, Fredrik and Gerdtham, Ulf and Gralén, Katarina and Gudjonsson, Sigurdur and Jahnson, Staffan and Johansson, Irene and Hagberg, Oskar and Larsson, Staffan and Lind, Anna Karin and Löfgren, Anneli and Wanegård, Jenny and Åberg, Hanna and Nilbert, Mef},
  issn         = {0007-0920},
  keyword      = {urologic care ,macroscopic haematuria},
  language     = {eng},
  month        = {08},
  pages        = {770--775},
  publisher    = {Nature Publishing Group},
  series       = {British Journal of Cancer},
  title        = {Fast-track access to urologic care for patients with macroscopic haematuria is efficient and cost-effective : results from a prospective intervention study},
  url          = {http://dx.doi.org/10.1038/bjc.2016.265},
  volume       = {115},
  year         = {2016},
}